糖尿病患者COVID-19感染后的心理状态变化及其影响因素
Changes in Psychological Status of Diabetic Patients after COVID-19 Infection and Its Influencing Factors
DOI: 10.12677/acm.2024.1451594, PDF,   
作者: 余苗佳:湖南师范大学附属第一医院(湖南省人民医院),湖南 长沙;张 弛:湖南师范大学附属第一医院(湖南省人民医院内分泌科),湖南 长沙
关键词: 糖尿病COVID-19心理状况Diabetes Mellitus COVID-19 Psychological Condition
摘要: 糖尿病与许多神经精神疾病有关,尤其是焦虑、抑郁。众所周知,糖尿病患者的抑郁症发生率是普通人群的2~3倍。糖尿病症状、并发症、疾病负担加重、自我护理不足、残疾和生活质量下降在共病抑郁和/或焦虑患者中更常见。压力是糖尿病患者的主要危险因素,它使血糖控制恶化,从而导致更多的症状和并发症。全球COVID-19爆发对大多数人来说都是一次压力很大的经历,糖尿病患者特别容易受到COVID-19不良后果的影响。研究表明,COVID-19大流行对糖尿病等慢性病患者的心理影响大于非慢性病患者。COVID-19后糖尿病患者心理状况会产生变化,糖尿病患者COVID-19感染后的心理状态的变化及其影响因素极其复杂,本文旨在分析糖尿病患者COVID-19感染后心理状态的变化及其影响因素,并对糖尿病患者存在焦虑抑郁患者的心理干预及整体治疗提供指导。
Abstract: Diabetes is associated with many neuropsychiatric disorders, especially anxiety and depression. Depression is known to be 2~3 times more common in people with diabetes than in the general population. Diabetic symptoms, complications, increased disease burden, inadequate self-care, disability, and decreased quality of life are more common in patients with co-morbid depression and/or anxiety. Stress is a major risk factor for people with diabetes and worsens glycaemic control, leading to more symptoms and complications. A global COVID-19 outbreak is a stressful experience for most people, and people with diabetes are particularly vulnerable to the adverse consequences of COVID-19. Studies have shown that the psychological impact of the COVID-19 pandemic on patients with chronic diseases such as diabetes mellitus is greater than that of patients with non-chronic diseases. Changes in the psychological status of diabetic patients occur after COVID-19. Changes in the psychological state of diabetic patients after COVID-19 infection and the factors influencing them and their complexity are discussed in this paper. The purpose of this paper is to analyse the changes in the psychological state of diabetic patients after COVID-19 infection and its influencing factors, and to provide guidance for psychological intervention and overall treatment of diabetic patients with anxiety and depression
文章引用:余苗佳, 张弛. 糖尿病患者COVID-19感染后的心理状态变化及其影响因素[J]. 临床医学进展, 2024, 14(5): 1604-1610. https://doi.org/10.12677/acm.2024.1451594

参考文献

[1] Charnogursky, G., Lee, H. and Lopez, N. (2014) Diabetic Neuropathy. In: Biller, J. and Ferro, J.M., Eds., Neurologic Aspects of Systemic Disease Part II. Handbook of Clinical Neurology, Vol. 120, Elsevier, Amsterdam, 773-785. [Google Scholar] [CrossRef
[2] Feldman, E.L., Savelieff, M.G., Hayek, S.S., et al. (2020) COVID-19 and Diabetes: A Collision and Collusion of Two Diseases. Diabetes, 69, 2549-2565. [Google Scholar] [CrossRef] [PubMed]
[3] Avogaro, A., Albiero, M., Menegazzo, L., et al. (2011) Endothelial Dysfunction in Diabetes: The Role of Reparatory Mechanisms. Diabetes Care, 34, S285-S290. [Google Scholar] [CrossRef] [PubMed]
[4] Rickels, K. and Rynn, M. (2002) Pharmacotherapy of Generalized Anxiety Disorder. Journal of Clinical Psychiatry, 63, 9-16.
[5] GBD 2019 Diseases and Injuries Collaborators (2020) Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet, 396, 1204-1222.
[6] Garcia-Lara, R.A., Gomez-Urquiza, J.L., Membrive-Jimenez, M.J., et al. (2022) Anxiety, Distress and Stress among Patients with Diabetes during COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine, 12, Article 1412. [Google Scholar] [CrossRef] [PubMed]
[7] Schmitt, A., Kulzer, B., Reimer, A., et al. (2022) Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes: Results of a Randomized Controlled Trial (ECCE HOMO Study). Psychotherapy and Psychosomatics, 91, 107-122. [Google Scholar] [CrossRef] [PubMed]
[8] Garcia-Lara, R.A., Suleiman-Martos, N., Membrive-Jimenez, M.J., et al. (2022) Prevalence of Depression and Related Factors among Patients with Chronic Disease during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Diagnostics, 12, Article 3094. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, Y., Lopez, J.M., Bolge, S.C., et al. (2016) Depression among People with Type 2 Diabetes Mellitus, US National Health and Nutrition Examination Survey (NHANES), 2005-2012. BMC Psychiatry, 16, Article No. 88. [Google Scholar] [CrossRef] [PubMed]
[10] Golden, S.H., Shah, N., Naqibuddin, M., et al. (2017) The Prevalence and Specificity of Depression Diagnosis in a Clinic-Based Population of Adults with Type 2 Diabetes Mellitus. Psychosomatics, 58, 28-37. [Google Scholar] [CrossRef] [PubMed]
[11] Al-Sofiani, M.E., Albunyan, S., Alguwaihes, A.M., et al. (2021) Determinants of Mental Health Outcomes among People with and without Diabetes during the COVID-19 Outbreak in the Arab Gulf Region. Journal of Diabetes, 13, 339-352. [Google Scholar] [CrossRef] [PubMed]
[12] Mendenhall, E., Norris, S.A., Shidhaye, R., et al. (2014) Depression and Type 2 Diabetes in Low-and Middle-Income Countries: A Systematic Review. Diabetes Research and Clinical Practice, 103, 276-285. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, J., Zhou, D., Dai, Z., et al. (2021) Association between Systemic Immune-Inflammation Index and Diabetic Depression. Clinical Interventions in Aging, 16, 97-105. [Google Scholar] [CrossRef
[14] De Kloet, E.R., Joels, M. and Holsboer, F. (2005) Stress and the Brain: From Adaptation to Disease. Nature Reviews Neuroscience, 6, 463-475. [Google Scholar] [CrossRef] [PubMed]
[15] Moulton, C.D., Costafreda, S.G., Horton, P., et al. (2015) Meta-Analyses of Structural Regional Cerebral Effects in Type 1 and Type 2 Diabetes. Brain Imaging and Behavior, 9, 651-662. [Google Scholar] [CrossRef] [PubMed]
[16] Anita, N.Z., Forkan, N., Kamal, R., et al. (2021) Serum Soluble Epoxide Hydrolase Related Oxylipins and Major Depression in Patients with Type 2 Diabetes. Psychoneuroendocrinology, 126, Article 105149.
[17] Kawasaki, N., Asada, R., Saito, A., et al. (2012) Obesity-Induced Endoplasmic Reticulum Stress Causes Chronic Inflammation in Adipose Tissue. Scientific Reports, 2, Article No. 799. [Google Scholar] [CrossRef] [PubMed]
[18] Arnold, S.E., Arvanitakis, Z., Macauley-Rambach, S.L., et al. (2018) Brain Insulin Resistance in Type 2 Diabetes and Alzheimer Disease: Concepts and Conundrums. Nature Reviews Neurology, 14, 168-181. [Google Scholar] [CrossRef] [PubMed]
[19] Singh, M.K., Leslie, S.M., Packer, M.M., et al. (2019) Brain and Behavioral Correlates of Insulin Resistance in Youth with Depression and Obesity. Hormones and Behavior, 108, 73-83. [Google Scholar] [CrossRef] [PubMed]
[20] Kleinridders, A., Cai, W., Cappellucci, L, et al. (2015) Insulin Resistance in Brain Alters Dopamine Turnover and Causes Behavioral Disorders. Proceedings of the National Academy of Sciences of the United States of America, 112, 3463-3468. [Google Scholar] [CrossRef] [PubMed]
[21] Lyra, E.S.N., Lam, M.P., Soares, C.N., et al. (2019) Insulin Resistance as a Shared Pathogenic Mechanism between Depression and Type 2 Diabetes. Frontiers in Psychiatry, 10, Article 57. [Google Scholar] [CrossRef] [PubMed]
[22] Chong, A.C.N., Vogt, M.C., Hill, A.S., Brüning, J.C. and Zeltser, L.M. (2015) Central Insulin Signaling Modulates Hypothalamus-Pituitary-Adrenal Axis Responsiveness. Molecular Metabolism, 4, 83-92. [Google Scholar] [CrossRef] [PubMed]
[23] Alessi, J., De Oliveira, G.B., Franco, D.W., et al. (2020) Mental Health in the Era of COVID-19: Prevalence of Psychiatric Disorders in a Cohort of Patients with Type 1 and Type 2 Diabetes during the Social Distancing. Diabetology & Metabolic Syndrome, 12, Article No. 76. [Google Scholar] [CrossRef] [PubMed]
[24] Mazza, M.G., Palladini, M., De Lorenzo, R., et al. (2021) Persistent Psychopathology and Neurocognitive Impairment in COVID-19 Survivors: Effect of Inflammatory Biomarkers at Three-Month Follow-Up. Brain, Behavior, and Immunity, 94, 138-147. [Google Scholar] [CrossRef] [PubMed]
[25] Maes, M., Vandoolaeghe, E., Ranjan, R., et al. (1995) Increased Serum Interleukin-1-Receptor-Antagonist Concentrations in Major Depression. Journal of Affective Disorders, 36, 29-36. [Google Scholar] [CrossRef] [PubMed]
[26] Blume, J., Douglas, S.D. and Evans, D.L. (2011) Immune Suppression and Immune Activation in Depression. Brain, Behavior, and Immunity, 25, 221-229. [Google Scholar] [CrossRef] [PubMed]
[27] Cheng, Y., Desse, S., Martinez, A., et al. (2018) TNFalpha Disrupts Blood Brain Barrier Integrity to Maintain Prolonged Depressive-Like Behavior in Mice. Brain, Behavior, and Immunity, 69, 556-567. [Google Scholar] [CrossRef] [PubMed]
[28] Halaris, A. (2019) Inflammation and Depression but Where Does the Inflammation Come from? Current Opinion in Psychiatry, 32, 422-428. [Google Scholar] [CrossRef
[29] Dantzer, R. (2018) Neuroimmune Interactions: From the Brain to the Immune System and vice versa. Physiological Reviews, 98, 477-504. [Google Scholar] [CrossRef] [PubMed]
[30] Najjar, S., Pearlman, D.M., Alper, K., et al. (2013) Neuroinflammation and Psychiatric Illness. Journal of Neuroinflammation, 10, Article No. 816. [Google Scholar] [CrossRef] [PubMed]
[31] Onaolapo, A.Y. and Onaolapo, O.J. (2021) Glutamate and Depression: Reflecting a Deepening Knowledge of the Gut and Brain Effects of a Ubiquitous Molecule. World Journal of Psychiatry, 11, 297-315. [Google Scholar] [CrossRef] [PubMed]
[32] Tremblay, M.-E., Madore, C., Bordeleau, M., et al. (2020) Neuropathobiology of COVID-19: The Role for Glia. Frontiers in Cellular Neuroscience, 14, Article 592214. [Google Scholar] [CrossRef] [PubMed]
[33] Raony, I., De Figueiredo, C.S., Pandolfo, P., et al. (2020) Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health. Frontiers in Immunology, 11, Article 1170. [Google Scholar] [CrossRef] [PubMed]
[34] Yirmiya, R. and Goshen, I. (2011) Immune Modulation of Learning, Memory, Neural Plasticity and Neurogenesis. Brain, Behavior, and Immunity, 25, 181-213. [Google Scholar] [CrossRef] [PubMed]
[35] Stellwagen, D. and Malenka, R.C. (2006) Synaptic Scaling Mediated by Glial TNF-Alpha. Nature, 440, 1054-1059. [Google Scholar] [CrossRef] [PubMed]
[36] Bourgognon, J.-M. and Cavanagh, J. (2020) The Role of Cytokines in Modulating Learning and Memory and Brain Plasticity. Brain and Neuroscience Advances, 4, 239821282097980. [Google Scholar] [CrossRef] [PubMed]
[37] Felger, J.C. and Lotrich, F.E. (2013) Inflammatory Cytokines in Depression: Neurobiological Mechanisms and Therapeutic Implications. Neuroscience, 246, 199-229. [Google Scholar] [CrossRef] [PubMed]
[38] Singh, S., Roy, D., Sinha, K., et al. (2020) Impact of COVID-19 and Lockdown on Mental Health of Children and Adolescents: A Narrative Review with Recommendations. Psychiatry Research, 293, Article 113429. [Google Scholar] [CrossRef] [PubMed]
[39] Guo, Q., Zheng, Y., Shi, J., et al. (2020) Immediate Psychological Distress in Quarantined Patients with COVID-19 and Its Association with Peripheral Inflammation: A Mixed-Method Study. Brain, Behavior, and Immunity, 88, 17-27. [Google Scholar] [CrossRef] [PubMed]
[40] Juruena, M.F., Eror, F., Cleare, A.J., et al. (2020) The Role of Early Life Stress in HPA Axis and Anxiety. In: Kim, Y.K., Ed., Anxiety Disorders. Advances in Experimental Medicine and Biology, Vol. 1191, Springer, Singapore, 141-153. [Google Scholar] [CrossRef] [PubMed]
[41] Nemeroff, C.B., Widerlov, E., Bissette, G., et al. (1984) Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients. Science, 226, 1342-1344. [Google Scholar] [CrossRef] [PubMed]
[42] Raadsheer, F.C., Hoogendijk, W.J., Stam, F.C., et al. (1994) Increased Numbers of Corticotropin-Releasing Hormone Expressing Neurons in the Hypothalamic Paraventricular Nucleus of Depressed Patients. Neuroendocrinology, 60, 436-444. [Google Scholar] [CrossRef] [PubMed]
[43] Cruz-Pereira, J.S., Rea, K., Nolan, Y.M., et al. (2020) Depression’s Unholy Trinity: Dysregulated Stress, Immunity, and the Microbiome. Annual Review of Psychology, 71, 49-78. [Google Scholar] [CrossRef] [PubMed]
[44] Rajkumar, R.P. (2020) COVID-19 and Mental Health: A Review of the Existing Literature. Asian Journal of Psychiatry, 52, Article 102066. [Google Scholar] [CrossRef] [PubMed]
[45] Wang, C., Pan, R., Wan, X., et al. (2020) Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. International Journal of Environmental Research and Public Health, 17, Article 1729. [Google Scholar] [CrossRef] [PubMed]
[46] Donath, M.Y. and Shoelson, S.E. (2011) Type 2 Diabetes as an Inflammatory Disease. Nature Reviews Immunology, 11, 98-107. [Google Scholar] [CrossRef] [PubMed]
[47] Forbes, J.M. and Cooper, M.E. (2013) Mechanisms of Diabetic Complications. Physiological Reviews, 93, 137-188. [Google Scholar] [CrossRef] [PubMed]
[48] Chao, A.M., Wadden, T.A., Clark, J.M., et al. (2022) Changes in the Prevalence of Symptoms of Depression, Loneliness, and Insomnia in U.S. Older Adults with Type 2 Diabetes during the COVID-19 Pandemic: The Look AHEAD Study. Diabetes Care, 45, 74-82. [Google Scholar] [CrossRef] [PubMed]
[49] Bak, E., Marcisz-Dyla, E., Mlynarska, A., et al. (2020) Prevalence of Depressive Symptoms in Patients with Type 1 and 2 Diabetes Mellitus. Patient Preference and Adherence, 14, 443-454. [Google Scholar] [CrossRef
[50] Choudhary, A., Adhikari, S. and White, P.C. (2022) Impact of the COVID-19 Pandemic on Management of Children and Adolescents with Type 1 Diabetes. BMC Pediatrics, 22, Article No. 124. [Google Scholar] [CrossRef] [PubMed]
[51] Hossen, M.T., Shuvo, S.D., Mazumdar, S., et al. (2024) Determinants of Anxiety and Depression among Type 2 Diabetes Mellitus Patients: A Hospital-Based Study in Bangladesh Amid the COVID-19 Pandemic. Global Mental Health, 11, e13. [Google Scholar] [CrossRef] [PubMed]